Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELU) Cash from Financing Activities (2020 - 2025)

Celularity (CELU) has disclosed Cash from Financing Activities for 6 consecutive years, with $3.5 million as the latest value for Q3 2025.

  • On a quarterly basis, Cash from Financing Activities rose 4502.53% to $3.5 million in Q3 2025 year-over-year; TTM through Sep 2025 was $8.1 million, a 33.55% increase, with the full-year FY2024 number at $6.7 million, down 72.19% from a year prior.
  • Cash from Financing Activities was $3.5 million for Q3 2025 at Celularity, up from $1.6 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $100.4 million in Q3 2021 to a low of -$4.8 million in Q1 2021.
  • A 5-year average of $13.5 million and a median of $3.5 million in 2025 define the central range for Cash from Financing Activities.
  • Peak YoY movement for Cash from Financing Activities: tumbled 219.87% in 2021, then surged 4692.86% in 2024.
  • Celularity's Cash from Financing Activities stood at -$1.0 million in 2021, then skyrocketed by 266.17% to $1.7 million in 2022, then tumbled by 100.83% to -$14000.0 in 2023, then soared by 4692.86% to $643000.0 in 2024, then skyrocketed by 440.9% to $3.5 million in 2025.
  • Per Business Quant, the three most recent readings for CELU's Cash from Financing Activities are $3.5 million (Q3 2025), $1.6 million (Q2 2025), and $2.3 million (Q1 2025).